{{Rsnum
|rsid=1801030
|Gene=SULT1A1
|Chromosome=16
|position=28606164
|Orientation=minus
|GMAF=0.1074
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SULT1A1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}[[rs1801030]] (Met223Val) is a snp within [[SULT1A1]] (Sulfotransferase 1A1) and defines the SULT1A1*3 allele.

{{PharmGKB
|RSID=rs1801030
|Name_s=SULT1A1*3;SULT1A1:667A>G;SULT1A1:Met223Val
|Gene_s=SULT1A2, SULT1A1
|Feature=Intron, Exon/NonSyn
|Evidence=PubMed ID:9345314
|Annotation=SULT1A1*3 is the second most common SULT1A1 SNP.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA161845801
}}

{{PharmGKB
|RSID=rs1801030
|Name_s=SULT1A1*3
|Gene_s=SULT1A2, SULT1A1
|Feature=Intron, Exon/NonSyn
|Evidence=Web Resource:http://www.pharmgkb.org/search/annotatedGene/sult1a1/variant.jsp
|Annotation=Associated with increased substrate affinity in vitro.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=In-Depth
|PharmGKB Accession ID=PA161145154
}}

{{PMID Auto
|PMID=19287157
|Title=Sulfotransferase gene copy number variation: pharmacogenetics and function.
|OA=1
}}

{{GET Evidence
|gene=SULT1A1
|aa_change=Val223Met
|aa_change_short=V223M
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1801030
|overall_frequency_n=9363
|overall_frequency_d=10750
|overall_frequency=0.870977
|n_genomes=44
|n_genomes_annotated=0
|n_haplomes=77
|n_articles=0
|n_articles_annotated=0
|nblosum100=0
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}